{"id":"W2955283109","doi":"10.1158/1078-0432.ccr-18-3944","title":"Nivolumab in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: Efficacy and Safety in CheckMate 141 by Prior Cetuximab Use","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":160,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute of Cancer Research","funders":"National Institutes of Health; Ono Pharmaceutical; National Cancer Institute; National Institute for Health and Care Research; Bristol-Myers Squibb","keywords":"Cetuximab; Nivolumab; Medicine; Head and neck; Head and neck squamous-cell carcinoma; Oncology; Basal cell; Internal medicine; Head and neck cancer; Cancer; Surgery; Immunotherapy; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001338839,0.0001397029,0.0005050076,0.0001090209,0.00004971417,0.0000227024,0.0001480692,0.00008620034,0.0001296761],"category_scores_gemma":[0.0003283913,0.00007925872,0.00005107414,0.0005278035,0.0004768513,0.00008561914,0.0001370143,0.0006703094,0.000002134253],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001957637,"about_ca_system_score_gemma":0.0005215065,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00258203,"about_ca_topic_score_gemma":0.001748261,"domain_scores_codex":[0.9975963,0.0004115025,0.0006323283,0.0004284312,0.0005449632,0.0003865361],"domain_scores_gemma":[0.9982165,0.000987891,0.0001183457,0.0004081098,0.0001466253,0.0001225391],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.05462401,0.001106125,0.9130878,0.0003444382,0.00002297306,0.000005608052,0.0002680672,7.969841e-7,0.000188247,9.302763e-7,0.0004611784,0.02988978],"study_design_scores_gemma":[0.04304227,0.004450163,0.9495954,0.0004693466,0.00002134702,0.000001206188,0.00008004104,0.00005332394,0.0002722625,0.000002354042,0.001912811,0.00009949439],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9950423,0.002243613,2.792842e-7,0.0005737856,0.00009598887,0.001908677,0.00006098834,0.000004139157,0.00007023924],"genre_scores_gemma":[0.9982826,0.0008046416,0.00004339584,0.0001341798,0.00001567594,0.00003947626,0.000008388321,0.00002220197,0.0006495076],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03650754,"threshold_uncertainty_score":0.3903274,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09167109629543041,"score_gpt":0.4198247893083826,"score_spread":0.3281536930129522,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}